Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in advanced gastric cancer
NCT00548548Phase 3Completed
- Sponsor
- Genentech
- Start
- Sep 2007
- Primary completion
- Nov 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in gastric cancer (GC), sponsored by Genentech. Started Sep 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00548548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548548.